Slideshow 10 drugs to watch

Published
  • April 02 2014, 1:16am EDT
10 Images Total

Cymbalta

Used for: Depression


Manufactured by: Lilly


Estimated annual sales: $4.7 billion


Generic: duloxetine


Generic launch date: December 2013

Lidoderm 5%

Used for: Skin conditions


Manufactured by: Endo


Estimated annual sales: $1.3 billion


Generic: lidocaine topical patch


Generic launch date: September 2013

Content Continues Below


Niaspan

Used for: High blood cholesterol


Manufactured by: AbbVie


Estimated annual sales: $1.2 billion


Generic: niacin, extended release


Generic launch date: September 2013

AcipHex

Used for: Ulcer disease


Manufactured by: Eisai


Estimated annual sales: $901 million


Generic: rabeprazole


Generic launch date: November 2013

Content Continues Below


Suboxone Sublingual Tablets

Used for: Pain


Manufactured by: Reckitt Benkiser


Estimated annual sales: $697 million


Generic: buprenorphine/naloxone


Generic launch date: February 2013

Nexium

Used for: Ulcer disease


Manufactured by: AstraZeneca


Estimated annual sales: $6.1 billion


Generic: esomeprazole


Generic launch date: May 2014

Content Continues Below


Copaxone 20mg/mL

Used for: Mental/neurological disorders


Manufactured by: Teva


Estimated annual sales: $3.7 billion


Generic: glatiramer acetate


Generic launch date: May 2014

Diovan

Used for: High blood pressure/heart disease


Manufactured by: Novartis


Estimated annual sales $2.1 billion


Generic: valsartan


Generic launch date: Mid-2014

Content Continues Below


Renvela

Used for: Gastrointestinal disorders


Manufactured by: Genzyme


Estimated annual sales: $889 million


Generic: sevelamer carbonate


Generic launch date: March 2014

Lunesta

Used for: Sleep disorders


Manufactured by: Sunovion


Estimated annual sales: $852 million


Generic: eszopiclone


Generic launch date: April 2014